Contact Us
Quotes News NAV
Market Watch
01 Oct EOD
SENSEX
NIFTY
GOLD
SILVER
CRUDE OIL
 
Market Info EXPAND TICKER
You are here : Corporate Information   |  Company News
Your Result on : Corporate Information | Company News
Date Headline
23-Sep-2026 Glenmark receives EIR report for formulations facility in Goa
23-Sep-2026 Glenmark Pharma gets EIR for Goa facility from US FDA
22-Sep-2026 Glenmark Pharmaceuticals Ltd spurts 0.5%, gains for fifth straight session
11-Sep-2026 Glenmark Pharmaceuticals receives revision in credit ratings on bank loans
11-Sep-2026 Glenmark launches RYALTRIS® Nasal Spray in Brazil
26-Aug-2026 Glenmark Pharmaceuticals Ltd soars 1.8%, rises for third straight session
21-Aug-2026 Glenmark USA launches Calcium Gluconate Injection USP
21-Aug-2026 Glenmark Pharma's US arm launches Calcium Gluconate injection in various formats
20-Aug-2026 Glenmark Pharmaceuticals receives USFDA approval for Fluticasone Propionate Nasal Spray USP
03-Aug-2026 Glenmark Pharmaceuticals to convene AGM
<< < 1 2 3 4 > >> 
Detailed Quotes
MF Holdings
Company News
Profit and Loss
Quarterly Results
Share Holding Pattern
Deliverable Volumes
Historical Prices
Board of Directors
Director's Report
Peer Comparison
Score Board
Name Change
Financial Ratios
Company Background
Company Snapshot
Balance Sheet
Site Map | Disclaimer | Circular Reports | Research Reports | About Us | Feedback | Careers | Contact Us
Useful Links
Stock : Stock Price Quotes | Stock Market India | Stock Market Global | Corporate Announcement
Market News : Corporate News | Market Commentary | Corporate Results | Economy News | Other Markets | Hot Pursuit | Futures Market
Share Market Updates : BSE Top Gainers - Sensex | NSE Top Gainers - Nifty | BSE Top Losers - Sensex | NSE Top Losers - Nifty | BSE Most Active Scrip by Volume - Sensex |
NSE Most Active Scrip by Volume - Nifty | BSE Most Active Scrip by Value - Sensex | NSE Most Active Scrip by Value - Nifty | Advances and Declinces
Derivatives : Get Quotes | Daily Settlement Prices | Put-Call Ratio | Cost Of Carry
Global Indicator : Stock Market Global | Currency | ADR Prices | FII Investments | Mutual Fund Investments
Services : Equity | Derivatives | Commodities | Mutual Fund | Portfolio Management Services (PMS) | Initial Public Offer (IPO)
Members:
Sebi Regn.No. - BSE : INB010983738 | NSE : INB230983737 | F&O : INF230983737 | NSE Currency: INE230983737 | FMC REGN.MCX : MCX/TCM/CORP/0276 | NCDEX : NCDEX/TCM/CORP/0411
Email ID for redressal of Investor Complaints : investorgrievances@manumangal.com
2012 © MANUBHAI MANGALDAS SECURITIES PVT. LTD All rights reserved Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)